Tweet
28 August 2020
14:52 CEST+02:00
The Spanish Agency for Medicine and Health Products (AEMPS) has authorised the Phase II study of a vaccine being developed by Janssen, a subsidiary of US pharmaceutical giant Johnson & Johson.
Testing will be carried out on 190 volunteers at three hospitals in Spain who will join 550 volunteers from Germany and Belgium in the pioneering study which will begin next week and last two months.
It will focus in healthy people aged between 18 and 55 as well as those over 65.
14:52 CEST+02:00
The Spanish Agency for Medicine and Health Products (AEMPS) has authorised the Phase II study of a vaccine being developed by Janssen, a subsidiary of US pharmaceutical giant Johnson & Johson.
Testing will be carried out on 190 volunteers at three hospitals in Spain who will join 550 volunteers from Germany and Belgium in the pioneering study which will begin next week and last two months.
It will focus in healthy people aged between 18 and 55 as well as those over 65.
